Physician profile
Ronald Lynn Wright
NPI 1437190956
$9,253.53
in general payments reported to CMS, 2019-2025
31 companies · $642 in 2025
The $642 reported for 2025 was more than what 85% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $230 · 2021: $494 · 2022: $573 · 2023: $3,017 · 2024: $3,956 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,694 · Food and Beverage: $2,398 · Travel and Lodging: $507 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,693.95 |
| Food and Beverage | $2,397.56 |
| Travel and Lodging | $506.87 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,850.87 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $597.68 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $597.03 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $218.59 | 2021-2025 | |
| Coopersurgical, INC. | $213.49 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Exeltis, USA INC. | $172.47 | 2020-2025 | Slynd |
| Shield Therapeutics INC | $158.18 | 2023-2025 | Accrufer |
| Therapeuticsmd, INC. | $133.23 | 2021-2022 | |
| Gen-Probe Sales & Service, INC. | $127.63 | 2019 | |
| Pfizer INC. | $123.30 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $120.55 | 2022 | |
| Medtronic, INC. | $111.67 | 2024 | Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $101.34 | 2019-2021 | |
| Biogen, INC. | $93.53 | 2024-2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $77.34 | 2020-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $76.65 | 2021-2023 | Twirla |
| Sumitomo Pharma America, INC. | $76.61 | 2023-2025 | Myfembree |
| Avion Pharmaceuticals | $64.85 | 2020 | |
| Hologic Sales and Service, LLC | $63.90 | 2019-2025 | Aptima |
| Organon LLC | $57.59 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $44.28 | 2019-2024 | Gardasil, Gardasil 9 |
| Coloplast Corp | $32.22 | 2021-2025 | |
| Medline Industries Lp | $28.38 | 2019 | |
| Gynesonics, INC. | $16.08 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Convatec INC. | $16.06 | 2025 | |
| Daiichi Sankyo INC. | $16.06 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.84 | 2024 | Xifaxan |
| Axonics, INC. | $13.06 | 2021 | |
| Dysis Medical, INC. | $12.76 | 2020 | |
| Avanos Medical | $11.68 | 2019 | |
| Sage Therapeutics, LLC | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.